01/11/2021 11:54
Clarín.com
Society
Updated 01/11/2021 11:54 AM
The active principle of the
AstraZeneca
and
Oxford
coronavirus vaccine
being developed in Argentina would be ready to travel to Mexico - where it will be packaged -
on January 18
.
However, it is estimated that the ready-to-apply doses will arrive in the country only at the
end of March
.
The general director of American Regional Organizations and Mechanisms, Efraín Guadarrama, communicated through his Twitter account that
the date
for the transfer of vaccines from Argentina to Mexico
was advanced
.
On Thursday he announced that the component would be ready to arrive in Mexico "in 10 days", a date that will be met next Monday.
Both countries will be in charge of producing the necessary doses for Latin America and the Caribbean.
Last Monday, @COFEPRIS approved the @AstraZeneca vaccine.
Today I had the pleasure of accompanying Dr. @HLGatell to MAbxience to verify the progress of the active principle of the vaccine that will arrive in Mexico in 10 days.
pic.twitter.com/fFqeadIK5B
- Efraín Guadarrama (@efrain_gp) January 8, 2021
The AstraZeneca and Oxford University vaccine was
approved
by the National Administration of Drugs, Food, and Medical Technology (ANMAT) on December 30, for
emergency use
.
Thus Argentina became
one of the first countries to endorse it
, after the authorization given a few hours before by the health authority of the United Kingdom.
However, it will take
two to three more months
for it to be applied in the country.
When the agreement for the local production of the vaccine was announced, at the mAbxience plant in Garín, those responsible for the laboratory that belongs to the Insud group had already anticipated that they would not arrive before averaging the first quarter of 2021, since
complexes
must be carried out.
Product validation processes
, which are completed in Mexico and from there it will be distributed to all of Latin America with the exception of Brazil.
As
Clarín has
already published
, the first doses of the Oxford vaccine would be available in Argentina between the
end of March and the beginning of April
.
That date was ratified in the last hours by the Minister of Health, Ginés González García, who estimated for "the end of March" the arrival of "
a very important number of doses
of the vaccine that is manufactured here", by the pharmaceutical company AstraZeneca .
In that interim, the country would have at its disposal the new doses of the Russian
Sputnik V
vaccine
that will arrive between January and February.
They are expected to be from both the first and second doses.
The 9 million doses of vaccines from the Covax fund would also arrive by March or April, the Pan American Health Organization told this newspaper.
AstraZeneca and Oxford vaccine boxes ready to be applied, in Bristol.
The production carried out jointly by Argentina and Mexico advances.
Photo: AFP
As of today, there is a stock equivalent to
10 million doses
of the AstraZeneca vaccine that were produced in the country.
In mid-January that volume of the active ingredient of the vaccine will be sent to Mexico to be bottled.
There, the Liomont laboratory has to validate the batches and demonstrate safety and hygiene in the fragmentation and filling stage.
Then AstraZeneca will have to distribute the vaccines according to the commitments assumed in Latin America:
Argentina bought 22.4 million doses
.
The approval of the vaccine by ANMAT could be finalized before the end of the year despite the fact that the phase III trial had some methodological setbacks and the AstraZeneca laboratory had to repeat part of the experiment.
The problem arose when a group of volunteers had received two standard doses of the vaccine, with an efficacy of 62.1%.
Due to an inconvenience attributed to an accident, another group received
half a dose
and then a full dose, with which the efficacy rose to 90%.
Technically, this coronavirus vaccine is already in a position to be applied in our country, like that of Pfizer, which received the same endorsement from the local regulatory agency, and Sputnik V, which had another type of authorization, through a resolution of the Ministry of Health following the recommendation of ANMAT.
However, the Russian vaccine is the only one that is being applied for now in the country, since the contract with Pfizer is on hold.
Vaccination with Sputnik began in December in health personnel.
There are
300,000
doses of component 1. According to the latest update, carried out on Friday, at least a third (107,542) has already been applied.
DD